Inverness secures second injunction against Pfizer
This article was originally published in Clinica
Executive Summary
Inverness Medical Innovations (IMI) has been granted a preliminary injunction banning the sale of one of Pfizer's pregnancy tests. The enjoined product is a newer version of one that IMI obtained an injunction on in December last year (see Clinica No 1039, p 9).